PEDIATRIC BLOOD AND MARROW TRANSPLANT FOUNDATION INC (EIN 461432359) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Principal Officer

MICHAEL L NIEDER MD

Phone

7275156660

Tax Period

2023-01-01 to 2023-12-31

PEDIATRIC BLOOD AND MARROW TRANSPLANT FOUNDATION INC, founded in 2013, is a small nonprofit in the Medical Research sector that reported $334K in total revenue in fiscal year 2023. Revenue fell 24% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $168K, a strong 50% operating margin.

Mission

TO IMPROVE THE OUTCOMES OF HEMATOPOIETIC CELL TRANSPLANTATION IN CHILDREN AND ADOLESCENTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $333,957

Program Service Revenue $0

Investment Income $56

Other Revenue $0

TOTAL REVENUE $334,013

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $166,326

Other Expenses $166,326

TOTAL EXPENSES $166,326

Year-over-Year Comparison

	2023	2022	Change
Revenue	$334,013	$441,931	-0.2%
Expenses	$166,326	$98,904	+0.7%
Net Income	$167,687	$343,027	-0.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MICHAEL NIEDER	DIRECTOR	1.00	Director	$0	$0	$0
MITCHELL CAIRO	DIRECTOR	1.00	Director	$0	$0	$0
MICHAEL PULSIPHER	DIRECTOR	1.00	Director	$0	$0	$0
BETH HAMILTON	DIRECTOR	1.00	Director	$0	$0	$0
MATTHEW REGAN	DIRECTOR	1.00	Director	$0	$0	$0
ROSANNA CAPALBO	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$334,013	$166,326	$643,939	$167,687
2022	$441,931	$98,904	$476,252	$343,027
2019	$168,905	$115,989	$170,463	$52,916
2018	$110,750	$225,549	$117,547	$-114,799

PEDIATRIC BLOOD AND MARROW TRANSPLANT FOUNDATION INC